It’s no wonder that Cleveland Clinic has placed an increased emphasis on commercializing medical innovations by its doctors.
Cleveland Clinic CEO Toby Cosgrove revealed in a recent interview that the $78 million sale of Clinic neurotechnology spinoff Intelect Medical to Boston Scientific Corp. (NYSE:BSX) in January returned an impressive $28 million to the health system.